Literature DB >> 16085502

The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries.

Karl Fagerström1.   

Abstract

Tobacco--particularly smoked products--has been associated with great harm and growing public disapproval and can be expected to suffer in the marketplace. This situation has created opportunities for other less harmful nicotine-containing products such as smokeless tobacco and nicotine replacement products, which are gaining public support. Little is known about the level of nicotine intake in our society. Tobacco sales are known, but how much nicotine is extracted and actually absorbed by users is largely unknown. The present study is a first attempt to estimate uptake of nicotine from tobacco and nicotine replacement products and to map nicotine consumption in a few countries, with special emphasis on Sweden. Relevant pharmacokinetic studies for three types of nicotine-containing products (cigarettes, smokeless tobacco, and nicotine replacement products) were analyzed for bioavailable nicotine. Estimates of nicotine intake from each category were made. These were then multiplied by the amount consumed in the respective countries. Tobacco consumption statistics were usually from official records of taxed sales. In Sweden about 54% of all nicotine intake comes from smoked sources, 45% from nonsmoked tobacco, and 1.3% from nicotine replacement products. For men, 63% of the nicotine consumed comes from nonsmoked tobacco. Per-capita nicotine intake per year for adults aged 15 years or older is 3,321 mg for Austria, 3,043 mg for Sweden, 3,014 mg for Denmark, 2,955 mg for the United States, 2,244 mg for Norway, and 2,023 mg for Finland. Compared with cigarette smokers, snus users seem to have a somewhat higher daily intake (34 mg vs. 25 mg). The cleanest nicotine products, nicotine replacement products, represent a negligible part (about 1%) of the total nicotine consumption in most countries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085502     DOI: 10.1080/14622200500124875

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  8 in total

1.  [Smoking cessation must be professionalized].

Authors:  Michael Kunze; Ernest Groman
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

2.  Habitual nicotine-seeking in rats following limited training.

Authors:  A Loughlin; D Funk; K Coen; A D Lê
Journal:  Psychopharmacology (Berl)       Date:  2017-06-07       Impact factor: 4.530

3.  A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence.

Authors:  A C Edwards; H H Maes; N L Pedersen; K S Kendler
Journal:  Psychol Med       Date:  2010-04-21       Impact factor: 7.723

4.  Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling.

Authors:  Hiroshi Yamazaki; Kana Horiuchi; Ryohji Takano; Taku Nagano; Makiko Shimizu; Masato Kitajima; Norie Murayama; Fumiaki Shono
Journal:  Int J Environ Res Public Health       Date:  2010-09-01       Impact factor: 3.390

5.  Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden.

Authors:  Martin Lindström
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

6.  Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: Findings from the ITC four-country survey.

Authors:  Ron Borland; Jae Cooper; Ann McNeill; Richard O'Connor; K Michael Cummings
Journal:  Harm Reduct J       Date:  2011-08-23

7.  Tobacco harm reduction: an alternative cessation strategy for inveterate smokers.

Authors:  Brad Rodu; William T Godshall
Journal:  Harm Reduct J       Date:  2006-12-21

Review 8.  Harmful effects of nicotine.

Authors:  Aseem Mishra; Pankaj Chaturvedi; Sourav Datta; Snita Sinukumar; Poonam Joshi; Apurva Garg
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.